Talk of a $6.6bn deal for Elan
Wednesday, February 27, 2013 - 05:40
in Mathematics & Economics
Potential offer from Royalty Pharma comes as Elan ponders how to spend its cash from Tysabri rights
Potential offer from Royalty Pharma comes as Elan ponders how to spend its cash from Tysabri rights